Abstract

Drug discovery processes require drug-target interaction (DTI) prediction by virtual screenings with high accuracy. Compared with traditional methods, the deep learning method requires less time and domain expertise, while achieving higher accuracy. However, there is still room for improvement for higher performance with simplified structures. Meanwhile, this field is calling for multi-task models to solve different tasks. Here we report the GanDTI, an end-to-end deep learning model for both interaction classification and binding affinity prediction tasks. This model employs the compound graph and protein sequence data. It only consists of a graph neural network, an attention module and a multiple-layer perceptron, yet outperforms the state-of-the art methods to predict binding affinity and interaction classification on the DUD-E, human, and bindingDB benchmark datasets. This demonstrates our refined model is highly effective and efficient for DTI prediction and provides a new strategy for performance improvement.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call